Autoantibodies and Direct-acting Antivirals

计划入组 191 人 · 首次发布于 2018 年 6 月 25 日

Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence

计划入组 68 人 · 首次发布于 2017 年 6 月 23 日

Hepatitis C Positive Donor Into Hepatitis C Negative Recipients

首次发布于 2018 年 10 月 11 日

DCVax-Direct

PEC Direct

antivirals (Rosanto)

G.ST Antivirals GmbH

Austria

Direct Biologics, LLC

United States

Perrigo Direct, Inc.

United States

Atea Pharmaceuticals Completes Enrollment in Phase 3 Hepatitis C Trial with Novel Drug Combination

Poland Expands HCV Treatment to Children as Real-World Data Confirm High DAA Efficacy in Pediatric Patients

World Hepatitis Day Research Topics Highlight Gaps in Diagnosis, Treatment Access, and Pediatric Elimination of Viral Hepatitis